Disease Modifying Drugs are a group of compounds which alter the progression of MS. They have been shown to reduce the frequency and severity of relapses and slow the development of disability in some people.
Up until June 2006 there were traditionally two types of Disease Modifying Drugs (DMDs) used in the treatment of MS.
These were:
Beta interferon – which comes in two forms, Beta interferon 1a and Beta interferon 1b
& Glatiramer acetate
Although their effect is quite similar, they work in different ways.
Keep Informed with News and Information regarding Multiple Sclerosis. If not yet receiving the “Stu’s Views and MS Related News”, weekly M.S. e-newsletter, then please take 20 seconds to register at: https://www.msviewsandnews.org. – Thank you